Document is current
Any future updates will be listed below
-
Authors
Qin, Zhi Zhen
Van der Walt, Martie
Moyo, Sizulu
Ismail, Farzana
Maribe, Phaleng
Denkinger, Claudia M.
Zaidi, Sarah
Barrett, Rachael
Mvusi, Lindiwe
Tsibolane, Yolisa
Mkhondo, Nkateko
Zuma, Khangelani
Manda, Samuel
Koeppel, Lisa
Mthiyane, Thuli
Creswell, Jacob
-
Funding
Funding for this research was provided by:
Government of Canada
- License Information
-
More Information
Article History
Received: 22 January 2025
Accepted: 6 June 2025
First Online: 2 July 2025
Declarations
:
: The authors declare no competing interests.
: Anonymized CXR data was obtained via a data-sharing request to the South African Medical Research Council (SAMRC) that was approved by the National Department of Health, South Africa. The CXR data provided had undergone automatic anonymization and hashing, ensuring no manual data handling, and was securely stored on Stop TB Partnership’s server using Secure File Transfer Protocol (SFTP). All data on the server was only accessible to co-investigators. Ethical approval was obtained from the SAMRC (EC002-3/2020) and Heidelberg (S-488/2021). During the prevalence survey, informed consent was obtained from all participants, with additional assent and parental consent for those aged 15-18 years. The study was carried out in accordance with the relevant guidelines and regulations.
